[1]
Vandenbussche N,Laterza D,Lisicki M,Lloyd J,Lupi C,Tischler H,Toom K,Vandervorst F,Quintana S,Paemeleire K,Katsarava Z, Medication-overuse headache: a widely recognized entity amidst ongoing debate. The journal of headache and pain. 2018 Jul 13;
[PubMed PMID: 30003412]
[2]
Wilkinson SM, Becker WJ, Heine JA. Opiate use to control bowel motility may induce chronic daily headache in patients with migraine. Headache. 2001 Mar:41(3):303-9
[PubMed PMID: 11264692]
[3]
Boes CJ,Capobianco DJ, Chronic migraine and medication-overuse headache through the ages. Cephalalgia : an international journal of headache. 2005 May;
[PubMed PMID: 15839853]
[5]
. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society. Cephalalgia : an international journal of headache. 1988:8 Suppl 7():1-96
[PubMed PMID: 3048700]
[6]
The International Classification of Headache Disorders: 2nd edition. Cephalalgia : an international journal of headache. 2004;
[PubMed PMID: 14979299]
[7]
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia : an international journal of headache. 2018 Jan;
[PubMed PMID: 29368949]
[8]
Lipton RB, Serrano D, Nicholson RA, Buse DC, Runken MC, Reed ML. Impact of NSAID and Triptan use on developing chronic migraine: results from the American Migraine Prevalence and Prevention (AMPP) study. Headache. 2013 Nov-Dec:53(10):1548-63. doi: 10.1111/head.12201. Epub 2013 Aug 28
[PubMed PMID: 23992516]
[9]
Shahbeigi S,Fereshtehnejad SM,Mohammadi N,Golmakani MM,Tadayyon S,Jalilzadeh G,Pakdaman H, Epidemiology of headaches in Tehran urban area: a population-based cross-sectional study in district 8, year 2010. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2013 Jul;
[PubMed PMID: 23010877]
Level 2 (mid-level) evidence
[10]
GBD 2016 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet (London, England). 2017 Sep 16:390(10100):1345-1422. doi: 10.1016/S0140-6736(17)32366-8. Epub
[PubMed PMID: 28919119]
Level 2 (mid-level) evidence
[11]
Hagen K, Linde M, Steiner TJ, Stovner LJ, Zwart JA. Risk factors for medication-overuse headache: an 11-year follow-up study. The Nord-Trøndelag Health Studies. Pain. 2012 Jan:153(1):56-61. doi: 10.1016/j.pain.2011.08.018. Epub 2011 Oct 22
[PubMed PMID: 22018971]
[12]
Scher AI,Lipton RB,Stewart WF,Bigal M, Patterns of medication use by chronic and episodic headache sufferers in the general population: results from the frequent headache epidemiology study. Cephalalgia : an international journal of headache. 2010 Mar;
[PubMed PMID: 19614708]
[13]
He Z,Dong L,Zhang Y,Kong Q,Tan G,Zhou J, Metabolic syndrome in female migraine patients is associated with medication overuse headache: a clinic-based study in China. European journal of neurology. 2015 Aug;
[PubMed PMID: 25981360]
[14]
Radat F,Lanteri-Minet M, What is the role of dependence-related behavior in medication-overuse headache? Headache. 2010 Nov;
[PubMed PMID: 20807250]
[15]
Shand B,Goicochea MT,Valenzuela R,Fadic R,Jensen R,Tassorelli C,Nappi G, Clinical and Demographical Characteristics of Patients with Medication Overuse Headache in Argentina and Chile: Analysis of the Latin American Section of COMOESTAS Project. The journal of headache and pain. 2015;
[PubMed PMID: 26382855]
[16]
Cevoli S, Sancisi E, Grimaldi D, Pierangeli G, Zanigni S, Nicodemo M, Cortelli P, Montagna P. Family history for chronic headache and drug overuse as a risk factor for headache chronification. Headache. 2009 Mar:49(3):412-8. doi: 10.1111/j.1526-4610.2008.01257.x. Epub
[PubMed PMID: 19267785]
[17]
Sarchielli P, Corbelli I, Messina P, Cupini LM, Bernardi G, Bono G, Di Piero V, Petolicchio B, Livrea P, Prudenzano MP, Pini LA, Sandrini G, Allena M, Tedeschi G, Russo A, Caproni S, Beghi E, Calabresi P, SAMOHA Study Group. Psychopathological comorbidities in medication-overuse headache: a multicentre clinical study. European journal of neurology. 2016 Jan:23(1):85-91. doi: 10.1111/ene.12794. Epub 2015 Jul 31
[PubMed PMID: 26228376]
[18]
Bendtsen L,Munksgaard S,Tassorelli C,Nappi G,Katsarava Z,Lainez M,Leston J,Fadic R,Spadafora S,Stoppini A,Jensen R, Disability, anxiety and depression associated with medication-overuse headache can be considerably reduced by detoxification and prophylactic treatment. Results from a multicentre, multinational study (COMOESTAS project). Cephalalgia : an international journal of headache. 2014 May;
[PubMed PMID: 24322480]
[19]
Johnson JL, Hutchinson MR, Williams DB, Rolan P. Medication-overuse headache and opioid-induced hyperalgesia: A review of mechanisms, a neuroimmune hypothesis and a novel approach to treatment. Cephalalgia : an international journal of headache. 2013 Jan:33(1):52-64. doi: 10.1177/0333102412467512. Epub 2012 Nov 9
[PubMed PMID: 23144180]
[20]
Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain. 2011 Mar:152(3 Suppl):S2-S15. doi: 10.1016/j.pain.2010.09.030. Epub 2010 Oct 18
[PubMed PMID: 20961685]
[21]
Schwedt TJ, Chong CD. Medication Overuse Headache: Pathophysiological Insights from Structural and Functional Brain MRI Research. Headache. 2017 Jul:57(7):1173-1178. doi: 10.1111/head.13037. Epub 2017 Feb 3
[PubMed PMID: 28160280]
[22]
Lai TH, Wang SJ. Neuroimaging Findings in Patients with Medication Overuse Headache. Current pain and headache reports. 2018 Jan 16:22(1):1. doi: 10.1007/s11916-018-0661-0. Epub 2018 Jan 16
[PubMed PMID: 29340793]
[23]
Srikiatkhachorn A, Tarasub N, Govitrapong P. Effect of chronic analgesic exposure on the central serotonin system: a possible mechanism of analgesic abuse headache. Headache. 2000 May:40(5):343-50
[PubMed PMID: 10849027]
[24]
Di Lorenzo C, Coppola G, Currà A, Grieco G, Santorelli FM, Lepre C, Porretta E, Pascale E, Pierelli F. Cortical response to somatosensory stimulation in medication overuse headache patients is influenced by angiotensin converting enzyme (ACE) I/D genetic polymorphism. Cephalalgia : an international journal of headache. 2012 Dec:32(16):1189-97. doi: 10.1177/0333102412461890. Epub 2012 Oct 10
[PubMed PMID: 23053304]
[26]
Andersen S, Skorpen F. Variation in the COMT gene: implications for pain perception and pain treatment. Pharmacogenomics. 2009 Apr:10(4):669-84. doi: 10.2217/pgs.09.13. Epub
[PubMed PMID: 19374521]
[27]
Serretti A,Calati R,Mandelli L,De Ronchi D, Serotonin transporter gene variants and behavior: a comprehensive review. Current drug targets. 2006 Dec;
[PubMed PMID: 17168841]
[28]
De Felice M,Ossipov MH,Wang R,Lai J,Chichorro J,Meng I,Dodick DW,Vanderah TW,Dussor G,Porreca F, Triptan-induced latent sensitization: a possible basis for medication overuse headache. Annals of neurology. 2010 Mar;
[PubMed PMID: 20373344]
[29]
Coppola G, Currà A, Di Lorenzo C, Parisi V, Gorini M, Sava SL, Schoenen J, Pierelli F. Abnormal cortical responses to somatosensory stimulation in medication-overuse headache. BMC neurology. 2010 Dec 30:10():126. doi: 10.1186/1471-2377-10-126. Epub 2010 Dec 30
[PubMed PMID: 21192822]
[32]
Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia : an international journal of headache. 2013 Jul:33(9):629-808. doi: 10.1177/0333102413485658. Epub
[PubMed PMID: 23771276]
[34]
Lagman-Bartolome AM,Lawler V,Lay C, Headache Education Active-Waiting Directive: A Program to Enhance Well-Being During Long Referral Wait Times. Headache. 2018 Jan
[PubMed PMID: 29131328]
[35]
Rossi P, Di Lorenzo C, Faroni J, Cesarino F, Nappi G. Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs. Cephalalgia : an international journal of headache. 2006 Sep:26(9):1097-105
[PubMed PMID: 16919060]
Level 1 (high-level) evidence
[36]
Schwedt TJ,Hentz JG,Sahai-Srivastava S,Murinova N,Spare NM,Treppendahl C,Martin VT,Birlea M,Digre K,Watson D,Leonard M,Robert T,Dodick DW,MOTS Investigators., Patient-Centered Treatment of Chronic Migraine With Medication Overuse: A Prospective, Randomized, Pragmatic Clinical Trial. Neurology. 2022 Apr 5
[PubMed PMID: 35169011]
Level 2 (mid-level) evidence
[37]
Cheung V,Amoozegar F,Dilli E, Medication overuse headache. Current neurology and neuroscience reports. 2015 Jan;
[PubMed PMID: 25398377]
[38]
Saper JR, Da Silva AN. Medication overuse headache: history, features, prevention and management strategies. CNS drugs. 2013 Nov:27(11):867-77. doi: 10.1007/s40263-013-0081-y. Epub
[PubMed PMID: 23925669]
[39]
Diener HC, Dodick DW, Goadsby PJ, Bigal ME, Bussone G, Silberstein SD, Mathew N, Ascher S, Morein J, Hulihan JF, Biondi DM, Greenberg SJ. Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse. Cephalalgia : an international journal of headache. 2009 Oct:29(10):1021-7. doi: 10.1111/j.1468-2982.2009.01859.x. Epub 2009 Apr 23
[PubMed PMID: 19735529]
[40]
Russell MB, Lundqvist C. Prevention and management of medication overuse headache. Current opinion in neurology. 2012 Jun:25(3):290-5. doi: 10.1097/WCO.0b013e328352c431. Epub
[PubMed PMID: 22547100]
Level 3 (low-level) evidence
[41]
Aurora SK, Dodick DW, Turkel CC, DeGryse RE, Silberstein SD, Lipton RB, Diener HC, Brin MF, PREEMPT 1 Chronic Migraine Study Group. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia : an international journal of headache. 2010 Jul:30(7):793-803. doi: 10.1177/0333102410364676. Epub 2010 Mar 17
[PubMed PMID: 20647170]
Level 1 (high-level) evidence
[42]
Diener HC,Dodick DW,Aurora SK,Turkel CC,DeGryse RE,Lipton RB,Silberstein SD,Brin MF, OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia : an international journal of headache. 2010 Jul;
[PubMed PMID: 20647171]
Level 1 (high-level) evidence
[43]
Silberstein SD, Blumenfeld AM, Cady RK, Turner IM, Lipton RB, Diener HC, Aurora SK, Sirimanne M, DeGryse RE, Turkel CC, Dodick DW. OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline. Journal of the neurological sciences. 2013 Aug 15:331(1-2):48-56. doi: 10.1016/j.jns.2013.05.003. Epub 2013 Jun 19
[PubMed PMID: 23790235]
[44]
Tassorelli C, Jensen R, Allena M, De Icco R, Sances G, Katsarava Z, Lainez M, Leston J, Fadic R, Spadafora S, Pagani M, Nappi G, the COMOESTAS Consortium. A consensus protocol for the management of medication-overuse headache: Evaluation in a multicentric, multinational study. Cephalalgia : an international journal of headache. 2014 Aug:34(9):645-655
[PubMed PMID: 24558185]
Level 3 (low-level) evidence
[45]
Pascual J, Berciano J. [Daily chronic headache in patients with migraine induced by abuse of ergotamine-analgesics: response due to a protocol of outpatient treatment]. Neurologia (Barcelona, Spain). 1993 Aug-Sep:8(7):212-5
[PubMed PMID: 8104438]
[46]
Smith TR. Low-dose tizanidine with nonsteroidal anti-inflammatory drugs for detoxification from analgesic rebound headache. Headache. 2002 Mar:42(3):175-7
[PubMed PMID: 11903539]
[47]
Rabe K, Pageler L, Gaul C, Lampl C, Kraya T, Foerderreuther S, Diener HC, Katsarava Z. Prednisone for the treatment of withdrawal headache in patients with medication overuse headache: a randomized, double-blind, placebo-controlled study. Cephalalgia : an international journal of headache. 2013 Feb:33(3):202-7. doi: 10.1177/0333102412462638. Epub 2012 Oct 23
[PubMed PMID: 23093541]
Level 1 (high-level) evidence
[48]
Bøe MG, Mygland A, Salvesen R. Prednisolone does not reduce withdrawal headache: a randomized, double-blind study. Neurology. 2007 Jul 3:69(1):26-31
[PubMed PMID: 17475943]
Level 1 (high-level) evidence
[49]
Pageler L, Katsarava Z, Diener HC, Limmroth V. Prednisone vs. placebo in withdrawal therapy following medication overuse headache. Cephalalgia : an international journal of headache. 2008 Feb:28(2):152-6
[PubMed PMID: 18039339]
[50]
Williams DR, Stark RJ. Intravenous lignocaine (lidocaine) infusion for the treatment of chronic daily headache with substantial medication overuse. Cephalalgia : an international journal of headache. 2003 Dec:23(10):963-71
[PubMed PMID: 14984229]
[51]
Schwartz TH, Karpitskiy VV, Sohn RS. Intravenous valproate sodium in the treatment of daily headache. Headache. 2002 Jun:42(6):519-22
[PubMed PMID: 12167141]
[52]
Trucco M, Meineri P, Ruiz L, Gionco M, Gruppo Neurologico Ospedaliero Interregionale per lo Studio delle Cefalee (Neurological Hospital Interregional Group for the Study of Headaches). Medication overuse headache: withdrawal and prophylactic therapeutic regimen. Headache. 2010 Jun:50(6):989-97. doi: 10.1111/j.1526-4610.2010.01631.x. Epub 2010 Mar 5
[PubMed PMID: 20236349]
[53]
Probyn K, Bowers H, Caldwell F, Mistry D, Underwood M, Matharu M, Pincus T, CHESS Team. Prognostic factors for chronic headache: A systematic review. Neurology. 2017 Jul 18:89(3):291-301. doi: 10.1212/WNL.0000000000004112. Epub 2017 Jun 14
[PubMed PMID: 28615422]
Level 1 (high-level) evidence
[54]
Hagen K, Jensen R, Bøe MG, Stovner LJ. Medication overuse headache: a critical review of end points in recent follow-up studies. The journal of headache and pain. 2010 Oct:11(5):373-7. doi: 10.1007/s10194-010-0221-4. Epub 2010 May 16
[PubMed PMID: 20473701]
[55]
Bøe MG, Thortveit E, Vatne A, Mygland Å. Chronic headache with medication overuse: Long-term prognosis after withdrawal therapy. Cephalalgia : an international journal of headache. 2017 Nov:37(13):1215-1221. doi: 10.1177/0333102416672493. Epub 2016 Oct 5
[PubMed PMID: 27707950]
[56]
Zidverc-Trajkovic JJ, Pekmezovic T, Jovanovic Z, Pavlovic A, Mijajlovic M, Radojicic A, Sternic N. Long-term predictors of remission in patients treated for medication-overuse headache at a specialized headache center: A prospective cohort study. Cephalalgia : an international journal of headache. 2018 Feb:38(2):265-273. doi: 10.1177/0333102416683918. Epub 2016 Dec 11
[PubMed PMID: 27940881]
[57]
Katsarava Z, Muessig M, Dzagnidze A, Fritsche G, Diener HC, Limmroth V. Medication overuse headache: rates and predictors for relapse in a 4-year prospective study. Cephalalgia : an international journal of headache. 2005 Jan:25(1):12-5
[PubMed PMID: 15606564]
[58]
Zeeberg P, Olesen J, Jensen R. Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness. Cephalalgia : an international journal of headache. 2006 Oct:26(10):1192-8
[PubMed PMID: 16961785]
[59]
Pini LA, Cicero AF, Sandrini M. Long-term follow-up of patients treated for chronic headache with analgesic overuse. Cephalalgia : an international journal of headache. 2001 Nov:21(9):878-83
[PubMed PMID: 11903281]
[60]
Tfelt-Hansen P, Krabbe A. Ergotamine abuse. Do patients benefit from withdrawal? Cephalalgia : an international journal of headache. 1981 Mar:1(1):29-32
[PubMed PMID: 15645831]
[61]
Sances G, Ghiotto N, Galli F, Guaschino E, Rezzani C, Guidetti V, Nappi G. Risk factors in medication-overuse headache: a 1-year follow-up study (care II protocol). Cephalalgia : an international journal of headache. 2010 Mar:30(3):329-36. doi: 10.1111/j.1468-2982.2009.01934.x. Epub 2010 Feb 15
[PubMed PMID: 19614697]
[62]
Suhr B, Evers S, Bauer B, Gralow I, Grotemeyer KH, Husstedt IW. Drug-induced headache: long-term results of stationary versus ambulatory withdrawal therapy. Cephalalgia : an international journal of headache. 1999 Jan:19(1):44-9
[PubMed PMID: 10099859]
[63]
Bøe MG,Salvesen R,Mygland A, Chronic daily headache with medication overuse: predictors of outcome 1 year after withdrawal therapy. European journal of neurology. 2009 Jun;
[PubMed PMID: 19236455]
[64]
Grazzi L, Andrasik F, D'Amico D, Leone M, Usai S, Kass SJ, Bussone G. Behavioral and pharmacologic treatment of transformed migraine with analgesic overuse: outcome at 3 years. Headache. 2002 Jun:42(6):483-90
[PubMed PMID: 12167136]
[65]
Lai JT,Dereix JD,Ganepola RP,Nightingale PG,Markey KA,Aveyard PN,Sinclair AJ, Should we educate about the risks of medication overuse headache? The journal of headache and pain. 2014 Feb 13;
[PubMed PMID: 24524380]